A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria

Completed

• Conditions: Renal Disease

• Registration Number: NCT05967806
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of the D4325C00007 study is to identify and characterise patients with known or newly diagnosed CKD for possible participation in future renal clinical studies and to obtain an overview on current treatment choices for this patient group in different regions.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-07-20
• Study First Submitted QC: 2023-07-20
• Study Start: 2023-07-31
• Study First Posted: 2023-08-01
• Primary Completion: 2024-08-30
• Study Completion: 2024-08-30
• Status Verified: 2025-02
• Last Update Submitted: 2025-04-03
• Last Update Posted: 2025-04-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2575

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients with UACR>700mg/g or UPCR >1000mg/g and eGFR 20-90 mL/min/1.73 m2	approximately 10 months	Summary statistics

Secondary Outcome Measures

Name	Time	Method
Number and sort of antihypertensive drugs among patients in different geographical regions	approximately 10 months	Use of medications

Trial Locations

Locations (1)

Research Site; 🇻🇳 Ho Chi Minh City, Vietnam